InsidersTradesSigma
XSpray Pharma AB (publ) Stock: price and insider trades · Finland · FIN-FSA
Track the XSpray Pharma AB (publ) share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, XSpray Pharma AB (publ) has recorded 26 reports. The latest transaction was disclosed on 20 June 2026 (Purchase). Among the most active insiders: Anders Bladh. All data is free.
26
Insider Decl.
0
Thresholds
€6m
22 ops.
Buy Volume
€209,755
4 ops.
Sell Volume
28Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 20 June 2026
Declarations26 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
3,000 shares@ SEK 16.10100.0% of flowAktieFI:csv-274bc4dfb6dd6a54e89e
Ideal exit: 15 Mar 2027 (T+270)
5,061 shares@ SEK 15.14085.2% of flowAktieFI:csv-e92870d0716e14fbde1f
Ideal exit: 12 Mar 2027 (T+270)
44,939 shares@ SEK 14.797344.8% of flowAktieFI:csv-f1005a17a65414aac5fb
Ideal exit: 9 Mar 2027 (T+270)
5,061 shares@ SEK 15.14085.2% of flowAktieFI:csv-6746386fe3a680114523
Ideal exit: 12 Mar 2027 (T+270)
44,939 shares@ SEK 14.797344.8% of flowAktieFI:csv-66e18b62cb040051ea48
Ideal exit: 9 Mar 2027 (T+270)
2,010 shares@ SEK 14.860.7% of flowAktieFI:csv-8cbf3bef439aa85fe7af
Ideal exit: 9 Mar 2027 (T+270)
19,999 shares@ SEK 24.6024.3% of flowAktieFI:csv-4fbf40fdcff9ad01915b
Ideal exit: 28 Feb 2027 (T+270)
19,999 shares@ SEK 24.6024.3% of flowAktieFI:csv-7ac9bd21c56c54570d70
19,999 shares@ SEK 24.601.9% of flowAktieFI:csv-6461119e00293c8dd1b0
Ideal exit: 28 Feb 2027 (T+270)
26,620 shares@ SEK 24.6015.6% of flowAktieFI:csv-feea20af4542100eeb2c
26,620 shares@ SEK 24.6015.6% of flowAktieFI:csv-dcb71a634a77ee2acec8
Ideal exit: 28 Feb 2027 (T+270)
19,999 shares@ SEK 24.601.9% of flowAktieFI:A003Z630-1
Ideal exit: 28 Feb 2027 (T+270)
26,620 shares@ SEK 24.6022.7% of flowAktieFI:A003Z629-1
26,620 shares@ SEK 24.6022.7% of flowAktieFI:A003Z628-1
Ideal exit: 28 Feb 2027 (T+270)
19,999 shares@ SEK 24.6047.2% of flowAktieFI:A003Z630-2
Ideal exit: 28 Feb 2027 (T+270)
19,999 shares@ SEK 24.6047.2% of flowAktieFI:A003Z631-1
475,764 shares@ €1.853137.8% of flowBTA (betald tecknad aktie)FI:A003X725-1
Ideal exit: 16 Jan 2027 (T+270)
1,818 shares@ €1.85310.1% of flowBTA (betald tecknad aktie)FI:A003X724-1
Ideal exit: 16 Jan 2027 (T+270)
30,420 shares@ €1.853139.2% of flowBTA (betald tecknad aktie)FI:A003X722-1
Ideal exit: 16 Jan 2027 (T+270)
733,618 shares@ €1.853139.0% of flowBTA (betald tecknad aktie)FI:A003X719-1
Ideal exit: 16 Jan 2027 (T+270)
23,821 shares@ €3.20283.3% of flowBTA (betald tecknad aktie)FI:A003S242-2
Ideal exit: 9 Jun 2026 (T+270)
27,467 shares@ €3.185160.8% of flowBTA (betald tecknad aktie)FI:A003S244-1
Ideal exit: 6 Jun 2026 (T+270)
1,652 shares@ €3.1851100.0% of flowBTA (betald tecknad aktie)FI:A003S243-1
Ideal exit: 6 Jun 2026 (T+270)
430,000 shares@ €3.185158.8% of flowBTA (betald tecknad aktie)FI:A003S241-1
Ideal exit: 6 Jun 2026 (T+270)
186 shares@ €3.1851100.0% of flowBTA (betald tecknad aktie)FI:A003S257-1
Ideal exit: 6 Jun 2026 (T+270)
25 of 26 declarations
About XSpray Pharma AB (publ)
XSpray Pharma AB (publ) is a Swedish company focused on developing innovative pharmaceutical formulations. It is listed on the XSTO stock exchange.